Results 161 to 170 of about 13,707,731 (353)

A dog lover's dilemma: Airborne allergic contact dermatitis to tylosin

open access: yesJAAD Case Reports, 2021
Aditi Kale, BS, Anthony A. Gaspari, MD
doaj  

Composition of Brazilian and Chinese Propolis for Patch Testing. [PDF]

open access: yesContact Dermatitis
Calta E   +4 more
europepmc   +1 more source

Patch Testing with European Standard Allergens in Tunisian Patients [PDF]

open access: bronze, 2002
Slaheddine Marrakchi   +3 more
openalex   +1 more source

Microglia limit brain tumor development by restricting tumor cell proliferation and inducing T‐cell immunity

open access: yesMolecular Oncology, EarlyView.
Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun   +5 more
wiley   +1 more source

Composition of Myroxylon pereirae Resin and Colophonium for Patch Testing. [PDF]

open access: yesContact Dermatitis
de Groot A   +4 more
europepmc   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Patch Testing with Propolis of Different Geographical Origins in a Baseline Series. [PDF]

open access: yesActa Derm Venereol, 2021
Nyman GSA   +5 more
europepmc   +1 more source

Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients [PDF]

open access: green, 2003
Catharina Johansson   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy